Protection of corneal allografts by CTLA4-Ig

Cornea

Volumn 18, Issue 3, 1999, Pages 314-320

  Gebhardt, Bryan M ^a   Hodkin, Michael ^a   Varnell, Emily D ^a   Kaufman, Herbert E ^a  

^a LSU EYE CENTER   (United States)

Author keywords

Allograft; Coreceptor; Cornea; CTLA4 Ig; Rejection; UV B irradiation; Vascularized

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA THICKNESS; CORNEA TRANSPLANTATION; CORNEA VASCULARIZATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SLIT LAMP; ULTRAVIOLET B RADIATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; COMBINED MODALITY THERAPY; CORNEA; CORNEAL TRANSPLANTATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOSUPPRESSIVE AGENTS; MALE; RABBITS; RECOMBINANT FUSION PROTEINS; TRANSPLANTATION, HOMOLOGOUS; ULTRAVIOLET RAYS;

EID: 0032914469     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199905000-00013     Document Type: Article

References (37)

1. Price FW Jr, Whitson WE, Collins KS, Marks RG. Five-year corneal graft survival: a large, single-center patient cohort. Arch Ophthalmol 1993;111:799-805.
2. Polack FM. Histopathological and histochemical alterations in the early stages of corneal graft rejection. J Exp Med 1962;116:709-17.
3. Williams KA, Mann TS, Lewis M, Coster DJ. The role of resident accessory cells in corneal allograft rejection in the rabbit. Transplantation 1986;42:667-71.
4. Holland EJ, Chan C-C, Wetzig RP, Palestine AG, Nussenblatt RB. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model. Cornea 1991;10:374-80.
5. Holland EJ, Olsen TW, Chan C-C, Bergstrom L, Palestine AG, Nussenblatt RB. Kinetics of corneal transplant rejection in the rat penetrating keratoplasty model. Cornea 1994;13:317-23.
6. Wackenheim-Urlacher A, Kantelip B, Falkenrodt A, et al. T-cell repertoire of normal, rejected, and pathological corneas: phenotype and function. Cornea 1995;14:450-6.
7. Larkin DFP, Calder VL, Lightman SL. Identification and characterization of cells infiltrating the graft and aqueous humor in rat corneal allograft rejection. Clin Exp Immunol 1997;107:381-91.
8. Hill JC, Maske R, Watson P. Corticosteroids in corneal graft rejection: oral versus single pulse therapy. Ophthalmology 1991;98: 329-33.
9. Belin MW, Bouchard CS, Frantz S, Chmielinska J. Topical cyclosporine in high-risk corneal transplants. Ophthalmology 1989;96: 1144-50.
10. Zhao J-C, Jin X-Y. Local therapy of corneal allograft rejection with cyclosporine. Am J Ophthalmol 1995;119:189-94.
11. Gebhardt BM, Varnell ED, Kaufman HE. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection. J Ocul Pharmacol Ther 1995;11:509-17.
12. Mills RA, Jones DB, Winkler CR, Wallace GW, Wilhelmus KR. Topical FK-506 prevents experimental corneal allograft rejection. Cornea 1995;14:157-60.
13. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992;257:789-92.
14. Linsley PS, Wallace PM, Johnson J, et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992;257:792-4.
15. Wallace PM, Rodgers JN, Leytze GM, Johnson JS, Linsley PS. Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA4Ig treatment. J Immunol 1995;154:5885-95.
16. Bolling SF, Lin H, Wei R-Q, Linsley P, Turka LA. The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival. J Surg Res 1994;57:60-4.
17. Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol 1995;155:1165-74.
18. Roy-Chaudhury P, Nickerson PW, Manfro RC, et al. CTLA4Ig attenuates accelerated rejection (presensitization) in the mouse islet allograft model. Transplantation 1997;64:172-5.
19. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174:561-9.
20. Niederkorn JY, Mayhew E. UVB irradiation renders corneal allografts tolerogenic for allospecific delayed hypersensitivity responses. Immunology 1993;79:278-84.
21. Hill JC, Sarvan J, Maske R, Els WJ. Evidence that UV-B irradiation decreases corneal Langerhans cells and improves corneal graft survival in the rabbit. Transplantation 1994;57:1281-4.
22. Hill JC, Maske R. An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation 1988;46:26-30.
23. Chen YF, Gebhardt BM, Reidy JJ, Kaufman HE. Cyclosporine-containing collagen shields suppress corneal allograft rejection. Am J Ophthalmol 1990;109:132-7.
24. Michels RG, Kenyon KR, Maumenee AE. Retrocorneal fibrous membrane. Invest Ophthalmol 1972;11:822-31.
25. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology 1994;101:1536-47.
26. Williams KA, Muehlberg SM, Lewis RF, Coster DJ. Long-term outcome in corneal allotransplantation: the Australian Corneal Graft Registry. Transplant Proc 1997;29:983.27.
27. Hodkin MJ. Complications of penetrating keratoplasty. In: Kaufman HE, Barron BA, McDonald, eds. The cornea, 2nd ed. Boston: Butterworth-Heinemann, 1998:847-78.
28. Gebhardt BM. Immune reactions in the eye. In: Kaufman HE, Zimmerman TJ, eds. Current concepts in ophthalmology. St Louis: CV Mosby, 1976:236-43.
29. Gebhardt BM. Factors affecting corneal allograft rejection in inbred rats. Transplant Proc 1981;13:1091-3.
30. Braude LS, Chandler JW. Corneal allograft rejection. The role of the major histocompatibility complex. Surv Ophthalmol 1983;27: 290-305.
31. Ray-Keil L, Chandler JW. Rejection of murine heterotopic corneal transplants. Transplantation 1985;39:473-7.
32. Ross J, He Y-G, Pidherney M, Mellon J, Niederkorn JY. The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts. Transplantation 1991;52:857-61.
33. Haskova Z, Filipec M, Holan V. The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice. Folia Biol (Praha) 1996;42:105-11.
34. Chandler JW, Ray-Keil L, Gillette TE. Experimental corneal allograft rejection: description of murine model and a new hypothesis of immunopathogenesis. Curr Eye Res 1983;2:387-97.
35. Ray-Keil L, Chandler JW. Reduction in the incidence of rejection of heterotopic murine corneal transplants by pretreatment with ultraviolet radiation. Transplantation 1986;42:403-6.
36. Niederkorn JY, Callanan D, Ross JR. Prevention of the induction of allospecific cytotoxic T lymphocyte and delayed-type hypersensitivity responses by ultraviolet irradiation of corneal allografts. Transplantation 1990;50:281-6.
37. He Y-G, Niederkorn JY. Depletion of donor-derived Langerhans cells promotes corneal allograft survival. Cornea 1996;15:82-9.